Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![TheTradeXchange Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::2196092280.png) TradeXchange [@TheTradeXchange](/creator/twitter/TheTradeXchange) on x 20.8K followers
Created: 2025-07-22 12:00:45 UTC

$ATYR - aTyr Pharma Announces Last Patient Visit in Phase X EFZO-FITâ„¢ Study of Efzofitimod in Patients with Pulmonary SarcoidosisTopline results expected in the third quarter of 2025.


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947627875169145110/c:line.svg)

**Related Topics**
[$atyr](/topic/$atyr)

[Post Link](https://x.com/TheTradeXchange/status/1947627875169145110)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

TheTradeXchange Avatar TradeXchange @TheTradeXchange on x 20.8K followers Created: 2025-07-22 12:00:45 UTC

$ATYR - aTyr Pharma Announces Last Patient Visit in Phase X EFZO-FITâ„¢ Study of Efzofitimod in Patients with Pulmonary SarcoidosisTopline results expected in the third quarter of 2025.

XXXXX engagements

Engagements Line Chart

Related Topics $atyr

Post Link

post/tweet::1947627875169145110
/post/tweet::1947627875169145110